Fibrolamellar Carcinoma with DNAJB1-PRKACA Fusion in a 16-Year-Old: Case Report and Review of Literature
Fibrolamellar hepatocellular carcinoma (FLC) is a unique primary liver malignancy arising in noncirrhotic livers of young adults with an incidence of 0.02 per 100,000 in the USA (1). In the 5th edition of the WHO classification of the digestive system tumors published in 2019, fibrolamellar carcino...
Main Authors: | Varsha Prakash, Neha Varshney |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2022-07-01
|
Series: | Journal of Renal and Hepatic Disorders |
Subjects: | |
Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/147 |
Similar Items
-
Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
by: Stefanie S. Schalm, et al.
Published: (2023-01-01) -
Fibrolamellar hepatocellular carcinoma: a case report and gene analysis
by: Akira Watanabe, et al.
Published: (2023-09-01) -
Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
by: Nicolas A. Villa, et al.
Published: (2015-07-01) -
Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments
by: Jinjia Song, et al.
Published: (2024-11-01) -
Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
by: Seong Kyun Na
Published: (2022-09-01)